Nicotinell (Nicotine Polacrilex)

Nicotine polacrilex, the active ingredient in Nicotinell, is a nicotine replacement therapy presented as a buccal formulation for buccal use. It is used to help adult smokers reduce withdrawal symptoms and cravings during a quit attempt.

GNH USA supplies Nicotinell as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell is a nicotine replacement product that addresses tobacco‑related dependence and supports cessation efforts. - Smoking cessation: provides controlled nicotine to lessen cravings and withdrawal in adults trying to quit. - Tobacco dependence: helps manage nicotine addiction during a structured quit program. - Adjunct to counseling: can be combined with behavioral support to improve quit rates.

Nicotinell may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation or soreness - Hiccups or throat discomfort - Nausea or dyspepsia - Increased salivation - Metallic taste - Mild headache

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Chest pain or palpitations - Severe mouth ulceration - Persistent dizziness - Unexplained weight loss - Signs of nicotine toxicity (vomiting, confusion)

Before using Nicotinell, consider the following safety measures. - Cardiovascular assessment: evaluate heart disease risk, as nicotine may affect blood pressure. - Medical supervision: use under guidance of a healthcare professional, especially for chronic conditions. - Allergy check: avoid if known hypersensitivity to nicotine or formulation components. - Non‑smoker warning: not intended for individuals who do not use tobacco products. - Child safety: keep out of reach of children to prevent accidental ingestion. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Nicotinell can interact with other substances that influence nicotine metabolism or cardiovascular function.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Other nicotine products (patches, gum, e‑cigarettes): risk of nicotine overdose.

Moderate Interactions (Monitor Closely): - Caffeine: may enhance stimulant effects, causing jitteriness. - Certain antipsychotics (e.g., clozapine): nicotine can alter drug levels. - Warfarin: nicotine may affect anticoagulant metabolism. - Beta‑blockers: nicotine may reduce therapeutic efficacy.